Personalized Medicine and Inhibition of EGFR Signaling in Lung Cancer.

被引：148

作者：

Gazdar, Adi F. ^{[1
,2
]}

机构：

[1] Simmons Canc Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX USA

[2] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2009年 / 361卷 / 10期

关键词：

GROWTH-FACTOR RECEPTOR; THERAPY;

D O I：

10.1056/NEJMe0905763

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1018 / 1020

页数：3

共 10 条

[1] Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients
Cappuzzo, F
Varella-Garcia, M
Shigematsu, H
Domenichini, I
Bartolini, S
Ceresoli, GL
Rossi, E
Ludovini, V
Gregorc, V
Toschi, L
Franklin, WA
Crino, L
Gazdar, AF
Bunn, RA
Hirsch, FR
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) : 5007 - 5018
[2] The epidermal growth factor receptor: A role in repair of radiation-induced DNA damage
Chen, David J.
Nirodi, Chaitanya S.
[J]. CLINICAL CANCER RESEARCH, 2007, 13 (22) : 6555 - 6560
[3] Alterations in Genes of the EGFR Signaling Pathway and Their Relationship to EGFR Tyrosine Kinase Inhibitor Sensitivity in Lung Cancer Cell Lines
Gandhi, Jeet
Zhang, Jianling
Xie, Yang
Soh, Junichi
Shigematsu, Hisayuki
Zhang, Wei
Yamamoto, Hiromasa
Peyton, Michael
Girard, Luc
Lockwood, William W.
Lam, Wan L.
Varella-Garcia, Marileila
Minna, John D.
Gazdar, Adi F.
[J]. PLOS ONE, 2009, 4 (02):
[4] The hallmarks of cancer
Hanahan, D
Weinberg, RA
[J]. CELL, 2000, 100 (01) : 57 - 70
[5] Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Mok, Tony S.
Wu, Yi-Long
Thongprasert, Sumitra
Yang, Chih-Hsin
Chu, Da-Tong
Saijo, Nagahiro
Sunpaweravong, Patrapim
Han, Baohui
Margono, Benjamin
Ichinose, Yukito
Nishiwaki, Yutaka
Ohe, Yuichiro
Yang, Jin-Ji
Chewaskulyong, Busyamas
Jiang, Haiyi
Duffield, Emma L.
Watkins, Claire L.
Armour, Alison A.
Fukuoka, Masahiro
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (10) : 947 - 957
[6] Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer.
Rosell, Rafael
Moran, Teresa
Queralt, Cristina
Porta, Rut
Cardenal, Felipe
Camps, Carlos
Majem, Margarita
Lopez-Vivanco, Guillermo
Isla, Dolores
Provencio, Mariano
Insa, Amelia
Massuti, Bartomeu
Luis Gonzalez-Larriba, Jose
Paz-Ares, Luis
Bover, Isabel
Garcia-Campelo, Rosario
Angel Moreno, Miguel
Catot, Silvia
Rolfo, Christian
Reguart, Noemi
Palmero, Ramon
Miguel Sanchez, Jose
Bastus, Roman
Mayo, Clara
Bertran-Alamillo, Jordi
Angel Molina, Miguel
Javier Sanchez, Jose
Taron, Miquel
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (10) : 958 - U38
[7] Toward Noninvasive Genomic Screening of Lung Cancer Patients
Sequist, Lecia V.
Engelman, Jeffrey A.
Lynch, Thomas J.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (16) : 2589 - 2591
[8] Epidermal growth factor receptor mutations in lung cancer
Sharma, Sreenath V.
Bell, Daphne W.
Settleman, Jeffrey
Haber, Daniel A.
[J]. NATURE REVIEWS CANCER, 2007, 7 (03) : 169 - 181
[9] Unraveling the mystery of prognostic and predictive factors in epidermal growth factor receptor therapy
Shepherd, FA
Tsao, MS
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) : 1219 - 1220
[10] Erlotinib in previously treated non-small-cell lung cancer
Shepherd, FA
Pereira, JR
Ciuleanu, T
Tan, EH
Hirsh, V
Thongprasert, S
Campos, D
Maoleekoonpiroj, S
Smylie, M
Martins, R
van Kooten, M
Dediu, M
Findlay, B
Tu, DS
Johnston, D
Bezjak, A
Clark, G
Santabárbara, P
Seymour, L
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02) : 123 - 132

← 1 →